source
- Skylark Bio launches first-in-human gene therapy trial targeting deafnessSkylark Bio, which has operated in stealth, announced that it has dosed the first patient in a gene-therapy trial aimed at treating hearing loss. The study marks the company's entry into the emergi…
- French study finds stopping statins in low-risk adults over 75 does not raise mortalityA new French non-inferiority study published in Lancet Healthy Longevity examined whether discontinuing statin therapy in people older than 75 who have no prior cardiovascular disease would affect…